Molecular cancer biomarkers are any measurable molecular indicator of risk of cancer,
occurrence of cancer, or patient outcome. They may include germline or somatic genetic …

Over the last four decades, methodological innovations have continuously changed
transcriptome profiling. It is now feasible to sequence and quantify the transcriptional outputs …

Colorectal cancer (CRC) is a prevalent and life-threatening cancer closely associated with
the gut microbiota. Probiotics, as a vital microbiota group, interact with the host's colonic …

Colorectal cancer is a frequent neoplasm in western countries, mainly due to dietary and
behavioral factors. Its incidence is growing in developing countries for the westernization of …

Although cancer initiation and progression are generally associated with the accumulation
of somatic mutations,, substantial epigenomic alterations underlie many aspects of …

B-Raf proto-oncogene serine/threonine-protein kinase (BRAF) is frequently altered in
multiple cancer types, and BRAF V600 mutations act as a prime target for precision therapy …

Simple Summary Human colorectal cancer (CRC) is a global health burden, most notably for
minority populations. While screening tools have helped improve disease detection and …

Rheumatoid arthritis (RA) is a complex condition that displays heterogeneity in disease
severity and response to standard treatments between patients. Failure rates for …

Colorectal cancer (CRC) is a complex disease characterized by genetic and epigenetic
alterations, playing a crucial role in its development and progression. This review aims to …

DNA methylation is a fundamental mechanism of epigenetic control in cells and its
dysregulation is strongly implicated in cancer development. Cancers possess an extensively …